Cantor Fitzgerald Initiates Coverage On Nuvectis Pharma with Overweight Rating

Benzinga · 4d ago
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Nuvectis Pharma (NASDAQ:NVCT) with a Overweight rating.